NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Bounces Back Amid Range-Bound Trading

On May 22, equity benchmarks showed a 0.3% increase, closing higher on the Nifty 50. Market breadth remained slightly positive, with 1,539 shares advancing against 1,407 declining shares on the NSE. Despite this, a strong move beyond last week's high is required for further market upside, otherwise, range-bound trading may continue.

Short-Term Trading Ideas

Sun Pharma Advanced Research Company

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Sun Pharma Advanced Research Company (SPARC) has decisively surpassed the past one-year consolidation zone around Rs 189 on a closing basis, indicating a trend reversal on the medium-term chart. Rising volumes over the past four weeks signal increased participation. The daily and weekly Bollinger Band buy signals indicate strengthening momentum, while the daily, weekly, and monthly Relative Strength Index (RSI) remains in favourable territory, indicating rising strength across all time frames. The stock is well placed above its 20, 50, 100, and 200-day simple moving averages (SMAs), which are also inching higher along with the price rise.

StockCMPTargetStop-Loss
Sun Pharma Advanced Research CompanyRs 209.77Rs 235, Rs 255Rs 195

Minda Corp

Minda Corp has decisively surpassed the multiple resistance zone around Rs 558 on a closing basis, accompanied by huge volumes, indicating strong participation in the breakout zone. The daily Bollinger Band buy signals indicate strengthening momentum, while the daily and weekly RSI remains in positive territory, reconfirming rising strength.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

StockCMPTargetStop-Loss
Minda CorpRs 574.65Rs 610, Rs 630Rs 555

Gland Pharma

Gland Pharma has delivered a consolidation breakout on a closing basis, following strong gains witnessed during the past week. The weekly and monthly Bollinger Band buy signals indicate increasing momentum, while the stock is well placed above its 20, 50, 100, and 200-day simple moving averages (SMAs). These averages are also gradually moving higher along with the price rise, reaffirming bullish sentiment.

StockCMPTargetStop-Loss
Gland PharmaRs 2,334Rs 2,460, Rs 2,700Rs 2,250

Techno Electric & Engineering Company

Techno Electric & Engineering Company has witnessed a breakout above the weekly down-sloping trendline near Rs 1,320 on a closing basis, accompanied by heavy trading volumes. The stock continues to form higher tops and higher bottoms on the weekly chart, indicating a strong uptrend.

StockCMPTargetStop-Loss
Techno Electric & Engineering CompanyRs 1,334.5Rs 1,410, Rs 1,485Rs 1,300

Other Recommendations

  • JSW Steel: Buy at current levels with a stop-loss below Rs 1,260, as it has consistently sustained above the pattern breakout and now appears poised for further acceleration.
  • GE Power India: Buy at current levels with a stop-loss at Rs 678, as previous resistance levels have now turned into support.
  • JB Chemicals and Pharmaceuticals: Buy with a target of Rs 2,350, Rs 2,500 and stop-loss at Rs 2,100.
  • Supriya Lifescience: Buy with a target of Rs 832 and stop-loss at Rs 740.
  • Endurance Technologies: Buy with a target of Rs 3,100 and stop-loss at Rs 2,650.

Investor Takeaway

Investors should consider a trend reversal in Sun Pharma Advanced Research Company (SPARC) based on its medium-term chart and rising volumes.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.